Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
15 matching registry records; showing 15 on this page, newest registry updates first. Search checked 2026-10-07 17:20 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Phase not reported / not applicableActive, not recruitingOBSERVATIONAL
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
2nd generation SU (drug) — also listed as: PIOGLITAZONE HCL/GLIMEPIRIDE, ROSIGLITAZONE MALEATE/GLIMEPIRIDE, GLIPIZIDE/METFORMIN HCL, GLYBURIDE,MICRONIZED, GLYBURIDE/METFORMIN HCL, GLIMEPIRIDE, GLYBURIDE, GLIPIZIDE
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Brigham and Women's Hospital Boston, Massachusetts, United States Site recruitment: Not reported
Start: 2025-09-15. Completion: 2029-06-30 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Intervention (drug)
Active Comparator (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Ohio State University Columbus, Ohio, United States Site recruitment: Not reported
Diabetes Mellitus, Type 2; Cardiovascular Diseases
Sponsor
Janssen Research & Development, LLC
Countries with listed sites
United States
Registry dates and results
Start: 2018-02-22. Completion: 2018-06-25 (may be estimated). No results posted in this registry response.
Products and interventions (9)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Canagliflozin (drug)
Empagliflozin (drug)
Dapagliflozin (drug)
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (drug)
Glucagon-like Peptide-1 (GLP-1) Agonist (drug)
Anti-hyperglycemic Agents (AHA) (drug)
Thiazolidinediones (TZD) (drug)
Sulfonylureas (SU) (drug)
Insulin (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Janssen Investigative Site Titusville, New Jersey, United States Site recruitment: Not reported
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders
Countries with listed sites
Bangladesh
Registry dates and results
Start: 2024-09. Completion: 2025-06 (may be estimated). No results posted in this registry response.
Products and interventions (9)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Omarigliptin (drug)
Sulphonylureas (drug)
Metformin (drug)
Other DPP4-i (drug)
Thiazolidinediones (drug)
Alpha-Glucosidase Inhibitor (drug)
Glucagon-Like Peptide-1 (drug)
Receptor Agonists (GLP1RA) (drug)
SGLT2 inhibitors (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
BIRDEM General Hospital Dhaka, Bangladesh Site recruitment: Not reported
Weight Loss; Diabetes Mellitus, Type 2; Quality of Life; Safety Issues
Sponsor
Jose Seijas Amigo
Countries with listed sites
Spain
Registry dates and results
Start: 2022-02-01. Completion: 2024-01-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
GLP-1 receptor agonist (drug)
Where the study takes place — 11 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Centro de Salud de Culleredo Culleredo, A Coruña, Spain Site recruitment: Not reported
Centro de Salud de Fene Fene, A Coruña, Spain Site recruitment: Not reported
Centro de Salud de Ribeira Ribeira, A Coruña, Spain Site recruitment: Not reported
Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, A Coruña, Spain Site recruitment: Not reported
Centro de Salud de Ribadeo Ribadeo, Lugo, Spain Site recruitment: Not reported
Centro de Salud de Vilalba Vilalba, Lugo, Spain Site recruitment: Not reported
Centro de Salud de O Carballiño O Carballiño, Ourense, Spain Site recruitment: Not reported
Centro de Salud Valmiñor Nigrán, Pontevedra, Spain Site recruitment: Not reported
Centro de Salud de O Ventorrillo A Coruña, Spain Site recruitment: Not reported
Centro de Salud de San Roque Lugo, Spain Site recruitment: Not reported
Centro de Salud Virxe Peregrina Pontevedra, Spain Site recruitment: Not reported
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Gastroenterology Department Erasme Hospital Brussels, Belgium Site recruitment: Not reported
Canada · Estonia · Germany · Israel · Italy · Romania · Slovakia · Spain · United States
Registry dates and results
Start: 2016-07-06. Completion: 2018-11-17 (may be estimated). Results are posted in this registry.
Products and interventions (7)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Insulin glargine/lixisenatide fixed ratio combination (drug) — also listed as: HOE901/AVE0010, Soliqua
liraglutide (drug) — also listed as: Victoza
exenatide (drug) — also listed as: Byetta
exenatide extended-release (drug) — also listed as: Bydureon
albiglutide (drug) — also listed as: Tanzeum
dulaglutide (drug) — also listed as: Trulicity
Background therapy: Oral Anti-diabetic Drug (Metformin, Pioglitazone, SGLT2 inhibitor) (drug)
Where the study takes place — 124 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Investigational Site Number 8400064 Birmingham, Alabama, United States Site recruitment: Not reported
Investigational Site Number 8400073 Fountain Hills, Arizona, United States Site recruitment: Not reported
Investigational Site Number 8400047 Phoenix, Arizona, United States Site recruitment: Not reported
Investigational Site Number 8400103 Bakersfield, California, United States Site recruitment: Not reported
Investigational Site Number 8400137 Fresno, California, United States Site recruitment: Not reported
Investigational Site Number 8400043 Huntington Park, California, United States Site recruitment: Not reported
Investigational Site Number 8400124 Lamont, California, United States Site recruitment: Not reported
Investigational Site Number 8400027 Lancaster, California, United States Site recruitment: Not reported
Investigational Site Number 8400098 Los Angeles, California, United States Site recruitment: Not reported
Investigational Site Number 8400013 Los Angeles, California, United States Site recruitment: Not reported
Investigational Site Number 8400042 Mission Hills, California, United States Site recruitment: Not reported
Investigational Site Number 8400006 Northridge, California, United States Site recruitment: Not reported
Investigational Site Number 8400021 Orange, California, United States Site recruitment: Not reported
Investigational Site Number 8400126 Rialto, California, United States Site recruitment: Not reported
Investigational Site Number 8400094 Santa Ana, California, United States Site recruitment: Not reported
Start: 2019-11-27. Completion: 2020-10-20 (may be estimated). No results posted in this registry response.
Products and interventions (6)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
IDegLira (drug)
IGlarLixi (drug)
Insulin/Canaglifozin (drug)
Insulin/Dapaglifozin (drug)
Insulin/Empaglifozin (drug)
Basal Bolus (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Unit of Endocrinology and Metabolic Diseases Naples, Italy Site recruitment: Not reported
Start: 2014-03-01. Completion: 2020-02-29 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
SGLT2 inhibitor (drug)
GLP-1 receptor agonist (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Division of Metabolic Diseases, University Hospital of Padova Padova, Italy Site recruitment: Not reported
Start: 2018-12-19. Completion: 2019-05-31 (may be estimated). No results posted in this registry response.
Products and interventions (6)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Long-acting GLP-1RA (drug)
Short-acting GLP-1RA (drug)
Human-based GLP-1RA (drug)
Exendin-based GLP-1RA (drug)
Fixed ratio BI/GLP-1RA combination (drug)
Flexible BI/GLP-1RA combination (drug)
Where the study takes place — 6 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Servizio di Diabetologia UOC Medicina Generale Cittadella, Padova, Italy Site recruitment: Not reported
U.O.S Diabetologia, Ospedale di Schiavonia Monselice, Padova, Italy Site recruitment: Not reported
U.O. Diabetologia ULSS2 Pieve di Soligo, Treviso, Italy Site recruitment: Not reported
U.O. Diabetologia e Dietetica ULSS6 Padova, Italy Site recruitment: Not reported
Azienda Ospedaliera di Padova Padova, Italy Site recruitment: Not reported
Diabetologia ULSS2 Treviso, Italy Site recruitment: Not reported
Start: 2015-07-16. Completion: 2018-07-23 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide (drug)
Lixisenatide (drug)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
St. Josef-Hospital, Universitätsklinik Bochum, Germany Site recruitment: Not reported
Profil Institut für Stoffwechselforschung GmbH Neuss, Germany Site recruitment: Not reported
Czechia · Finland · France · Germany · Hungary · Italy · Latvia · Lithuania · United Kingdom
Registry dates and results
Start: 2013-10. Completion: 2014-11 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
liraglutide (drug)
lixisenatide (drug)
Where the study takes place — 61 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Novo Nordisk Investigational Site Hradec Králové, Czechia Site recruitment: Not reported
Novo Nordisk Investigational Site Mladá Boleslav, Czechia Site recruitment: Not reported
Novo Nordisk Investigational Site Olomouc, Czechia Site recruitment: Not reported
Novo Nordisk Investigational Site Pilsen, Czechia Site recruitment: Not reported
Novo Nordisk Investigational Site Prostějov, Czechia Site recruitment: Not reported
Novo Nordisk Investigational Site Helsinki, Finland Site recruitment: Not reported
Novo Nordisk Investigational Site Jyväskylä, Finland Site recruitment: Not reported
Novo Nordisk Investigational Site Oulu, Finland Site recruitment: Not reported
Novo Nordisk Investigational Site Pori, Finland Site recruitment: Not reported
Novo Nordisk Investigational Site Rovaniemi, Finland Site recruitment: Not reported
Novo Nordisk Investigational Site Boulogne-Billancourt, France Site recruitment: Not reported
Novo Nordisk Investigational Site Corbeil-Essonnes, France Site recruitment: Not reported
Novo Nordisk Investigational Site Hinx, France Site recruitment: Not reported
Novo Nordisk Investigational Site La Rochelle, France Site recruitment: Not reported
Novo Nordisk Investigational Site Saint-Herblain, France Site recruitment: Not reported
Novo Nordisk Investigational Site Strasbourg, France Site recruitment: Not reported
Novo Nordisk Investigational Site Vénissieux, France Site recruitment: Not reported
Novo Nordisk Investigational Site Bad Lauterberg im Harz, Germany Site recruitment: Not reported
Novo Nordisk Investigational Site Berlin, Germany Site recruitment: Not reported
Novo Nordisk Investigational Site Bochum, Germany Site recruitment: Not reported
Novo Nordisk Investigational Site Dresden, Germany Site recruitment: Not reported
Novo Nordisk Investigational Site Duisburg, Germany Site recruitment: Not reported
Novo Nordisk Investigational Site Friedrichsthal, Germany Site recruitment: Not reported
Novo Nordisk Investigational Site Lampertheim, Germany Site recruitment: Not reported
Novo Nordisk Investigational Site Ludwigshafen, Germany Site recruitment: Not reported
Novo Nordisk Investigational Site Saint Ingbert, Germany Site recruitment: Not reported
Novo Nordisk Investigational Site Baja, Hungary Site recruitment: Not reported
Novo Nordisk Investigational Site Budapest, Hungary Site recruitment: Not reported
Novo Nordisk Investigational Site Budapest, Hungary Site recruitment: Not reported
Novo Nordisk Investigational Site Budapest, Hungary Site recruitment: Not reported
Novo Nordisk Investigational Site Gyula, Hungary Site recruitment: Not reported
Novo Nordisk Investigational Site Pécs, Hungary Site recruitment: Not reported
Novo Nordisk Investigational Site Salgótarján, Hungary Site recruitment: Not reported
Novo Nordisk Investigational Site Szeged, Hungary Site recruitment: Not reported
Novo Nordisk Investigational Site Catania, Italy Site recruitment: Not reported
Novo Nordisk Investigational Site Cittadella (PD), Italy Site recruitment: Not reported
Novo Nordisk Investigational Site Padova, Italy Site recruitment: Not reported
Novo Nordisk Investigational Site Palermo, Italy Site recruitment: Not reported
Novo Nordisk Investigational Site Terni, Italy Site recruitment: Not reported
Novo Nordisk Investigational Site Ogre, Latvia Site recruitment: Not reported
Novo Nordisk Investigational Site Riga, Latvia Site recruitment: Not reported
Novo Nordisk Investigational Site Riga, Latvia Site recruitment: Not reported
Novo Nordisk Investigational Site Riga, Latvia Site recruitment: Not reported
Novo Nordisk Investigational Site Riga, Latvia Site recruitment: Not reported
Novo Nordisk Investigational Site Kaunas, Lithuania Site recruitment: Not reported
Novo Nordisk Investigational Site Kaunas, Lithuania Site recruitment: Not reported
Novo Nordisk Investigational Site Klaipėda, Lithuania Site recruitment: Not reported
Novo Nordisk Investigational Site Šiauliai, Lithuania Site recruitment: Not reported
Novo Nordisk Investigational Site Vilnius, Lithuania Site recruitment: Not reported
Novo Nordisk Investigational Site Basingstoke, United Kingdom Site recruitment: Not reported
Novo Nordisk Investigational Site Bristol, United Kingdom Site recruitment: Not reported
Novo Nordisk Investigational Site Chester, United Kingdom Site recruitment: Not reported
Novo Nordisk Investigational Site Chiswick, United Kingdom Site recruitment: Not reported
Novo Nordisk Investigational Site Coventry, United Kingdom Site recruitment: Not reported
Novo Nordisk Investigational Site Derby, United Kingdom Site recruitment: Not reported
Novo Nordisk Investigational Site Devon, United Kingdom Site recruitment: Not reported
Novo Nordisk Investigational Site Great Yarmouth, United Kingdom Site recruitment: Not reported
Novo Nordisk Investigational Site Lancaster, United Kingdom Site recruitment: Not reported
Novo Nordisk Investigational Site Plymouth, United Kingdom Site recruitment: Not reported
Novo Nordisk Investigational Site Sandbach, United Kingdom Site recruitment: Not reported
Novo Nordisk Investigational Site Taunton, United Kingdom Site recruitment: Not reported
Start: 2010-08. Completion: 2010-11 (may be estimated). Results are posted in this registry.
Products and interventions (5)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Lixisenatide (AVE0010) (drug)
Pen auto-injector (device) — also listed as: OptiClik®
Liraglutide (drug)
Pre-filled pen injector (device) — also listed as: Victoza®
Metformin (drug)
Where the study takes place — 7 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Sanofi-Aventis Investigational Site Number 276006 Berlin, Germany Site recruitment: Not reported
Sanofi-Aventis Investigational Site Number 276004 Kiel, Germany Site recruitment: Not reported
Sanofi-Aventis Investigational Site Number 276002 Mainz, Germany Site recruitment: Not reported
Sanofi-Aventis Investigational Site Number 276003 Mannheim, Germany Site recruitment: Not reported
Sanofi-Aventis Investigational Site Number 276005 Mönchengladbach, Germany Site recruitment: Not reported
Sanofi-Aventis Investigational Site Number 276007 München, Germany Site recruitment: Not reported
Sanofi-Aventis Investigational Site Number 276001 Neuss, Germany Site recruitment: Not reported
Start: 2012-05. Completion: 2013-07 (may be estimated). Results are posted in this registry.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Lixisenatide (AVE0010) (drug)
Liraglutide (drug) — also listed as: Victoza®
Insulin Glargine (drug) — also listed as: Lantus® SoloSTAR®
Metformin (drug)
Where the study takes place — 8 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Investigational Site Number 276008 Berlin, Germany Site recruitment: Not reported
Investigational Site Number 276006 Berlin, Germany Site recruitment: Not reported
Investigational Site Number 276004 Kiel, Germany Site recruitment: Not reported
Investigational Site Number 276002 Mainz, Germany Site recruitment: Not reported
Investigational Site Number 276005 Mönchengladbach, Germany Site recruitment: Not reported
Investigational Site Number 276007 München, Germany Site recruitment: Not reported
Investigational Site Number 276003 Neu-Ulm, Germany Site recruitment: Not reported
Investigational Site Number 276001 Neuss, Germany Site recruitment: Not reported
Hospital Universitari Vall d'Hebron Research Institute
Countries with listed sites
Spain
Registry dates and results
Start: 2014-10. Completion: 2015-10 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Liraglutide (drug) — also listed as: Exenatide, Lixisenatide
metformin (drug) — also listed as: sulphonilurea
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain Site recruitment: Recruiting
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.
Investigational Site Number 8400009 Ventura, California, United States Site recruitment: Not reported
Investigational Site Number 8400071 Denver, Colorado, United States Site recruitment: Not reported
Investigational Site Number 8400036 Denver, Colorado, United States Site recruitment: Not reported
Investigational Site Number 8400114 Jacksonville, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400133 Miami, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400058 Port Charlotte, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400084 Tampa, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400112 West Palm Beach, Florida, United States Site recruitment: Not reported
Investigational Site Number 8400045 Lawrenceville, Georgia, United States Site recruitment: Not reported
Investigational Site Number 8400096 Snellville, Georgia, United States Site recruitment: Not reported
Investigational Site Number 8400023 Springfield, Illinois, United States Site recruitment: Not reported
Investigational Site Number 8400049 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400053 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400085 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400120 Avon, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400041 Evansville, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400038 Indianapolis, Indiana, United States Site recruitment: Not reported
Investigational Site Number 8400130 Council Bluffs, Iowa, United States Site recruitment: Not reported
Investigational Site Number 8400034 Lexington, Kentucky, United States Site recruitment: Not reported
Investigational Site Number 8400091 Lexington, Kentucky, United States Site recruitment: Not reported
Investigational Site Number 8400078 Marrero, Louisiana, United States Site recruitment: Not reported
Investigational Site Number 8400032 Metairie, Louisiana, United States Site recruitment: Not reported
Investigational Site Number 8400088 New Orleans, Louisiana, United States Site recruitment: Not reported
Investigational Site Number 8400033 Baltimore, Maryland, United States Site recruitment: Not reported
Investigational Site Number 8400051 Jefferson City, Missouri, United States Site recruitment: Not reported
Investigational Site Number 8400083 Papillion, Nebraska, United States Site recruitment: Not reported
Investigational Site Number 8400044 Henderson, Nevada, United States Site recruitment: Not reported
Investigational Site Number 8400079 Albany, New York, United States Site recruitment: Not reported
Investigational Site Number 8400061 New York, New York, United States Site recruitment: Not reported
Investigational Site Number 8400123 North Massapequa, New York, United States Site recruitment: Not reported
Investigational Site Number 8400095 Staten Island, New York, United States Site recruitment: Not reported
Investigational Site Number 8400067 West Seneca, New York, United States Site recruitment: Not reported
Investigational Site Number 8400111 Yonkers, New York, United States Site recruitment: Not reported
Investigational Site Number 8400020 Morehead City, North Carolina, United States Site recruitment: Not reported
Investigational Site Number 8400065 Wilmington, North Carolina, United States Site recruitment: Not reported
Investigational Site Number 8400018 Fargo, North Dakota, United States Site recruitment: Not reported
Investigational Site Number 8400019 Columbus, Ohio, United States Site recruitment: Not reported
Investigational Site Number 8400056 Dayton, Ohio, United States Site recruitment: Not reported
Investigational Site Number 8400125 Mentor, Ohio, United States Site recruitment: Not reported
Investigational Site Number 8400099 Oklahoma City, Oklahoma, United States Site recruitment: Not reported
Investigational Site Number 8400129 Scottdale, Pennsylvania, United States Site recruitment: Not reported
Investigational Site Number 8400076 Smithfield, Pennsylvania, United States Site recruitment: Not reported
Investigational Site Number 8400104 Warwick, Rhode Island, United States Site recruitment: Not reported
Investigational Site Number 8400090 Columbia, South Carolina, United States Site recruitment: Not reported
Investigational Site Number 8400139 Austin, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400001 Dallas, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400118 Edinburg, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400008 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400109 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400063 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400106 Houston, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400014 North Richland Hills, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400089 San Antonio, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400135 Schertz, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400075 Shavano Park, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400107 Sugar Land, Texas, United States Site recruitment: Not reported
Investigational Site Number 8400054 Orem, Utah, United States Site recruitment: Not reported
Investigational Site Number 8400025 Salt Lake City, Utah, United States Site recruitment: Not reported
Investigational Site Number 8400092 Weber City, Virginia, United States Site recruitment: Not reported
Investigational Site Number 1240003 Burlington, Canada Site recruitment: Not reported
Investigational Site Number 1240006 Corunna, Canada Site recruitment: Not reported
Investigational Site Number 1240002 Red Deer, Canada Site recruitment: Not reported
Investigational Site Number 1240001 Vancouver, Canada Site recruitment: Not reported
Investigational Site Number 2330002 Pärnu, Estonia Site recruitment: Not reported
Investigational Site Number 2330003 Tallinn, Estonia Site recruitment: Not reported
Investigational Site Number 2330001 Tallinn, Estonia Site recruitment: Not reported
Investigational Site Number 2330004 Viljandi, Estonia Site recruitment: Not reported
Investigational Site Number 2760001 Dresden, Germany Site recruitment: Not reported
Investigational Site Number 2760003 Oldenburg in Holstein, Germany Site recruitment: Not reported
Investigational Site Number 3760001 Haifa, Israel Site recruitment: Not reported
Investigational Site Number 3760002 Haifa, Israel Site recruitment: Not reported
Investigational Site Number 3760005 Jerusalem, Israel Site recruitment: Not reported
Investigational Site Number 3760006 Jerusalem, Israel Site recruitment: Not reported
Investigational Site Number 3760004 Tel Aviv, Israel Site recruitment: Not reported
Investigational Site Number 3800008 Bergamo, Italy Site recruitment: Not reported
Investigational Site Number 3800002 Bologna, Italy Site recruitment: Not reported
Investigational Site Number 3800001 Milan, Italy Site recruitment: Not reported
Investigational Site Number 3800006 Milan, Italy Site recruitment: Not reported
Investigational Site Number 3800005 Naples, Italy Site recruitment: Not reported
Investigational Site Number 3800004 Roma, Italy Site recruitment: Not reported
Investigational Site Number 3800003 Roma, Italy Site recruitment: Not reported
Investigational Site Number 6420004 Bacau, Romania Site recruitment: Not reported
Investigational Site Number 6420006 Brasov, Romania Site recruitment: Not reported
Investigational Site Number 6420001 Bucharest, Romania Site recruitment: Not reported
Investigational Site Number 6420008 Buzău, Romania Site recruitment: Not reported
Investigational Site Number 6420003 Cluj-Napoca, Romania Site recruitment: Not reported
Investigational Site Number 6420002 Oradea, Romania Site recruitment: Not reported
Investigational Site Number 6420009 Targoviste, Romania Site recruitment: Not reported
Investigational Site Number 6420007 Târgu Mureş, Romania Site recruitment: Not reported
Investigational Site Number 6420005 Timișoara, Romania Site recruitment: Not reported
Investigational Site Number 7030006 Bratislava, Slovakia Site recruitment: Not reported
Investigational Site Number 7030002 Lučenec, Slovakia Site recruitment: Not reported
Investigational Site Number 7030009 Ľubochňa, Slovakia Site recruitment: Not reported
Investigational Site Number 7030005 Malacky, Slovakia Site recruitment: Not reported
Investigational Site Number 7030007 Prešov, Slovakia Site recruitment: Not reported
Investigational Site Number 7030001 Rožňava, Slovakia Site recruitment: Not reported
Investigational Site Number 7030008 Sabinov, Slovakia Site recruitment: Not reported
Investigational Site Number 7030004 Trenčín, Slovakia Site recruitment: Not reported
Investigational Site Number 7030003 Žilina, Slovakia Site recruitment: Not reported
Investigational Site Number 7240012 Alzira, Spain Site recruitment: Not reported
Investigational Site Number 7240005 Barcelona, Spain Site recruitment: Not reported
Investigational Site Number 7240002 Ferrol, Spain Site recruitment: Not reported
Investigational Site Number 7240008 Málaga, Spain Site recruitment: Not reported
Investigational Site Number 7240011 Pozuelo de Alarcón, Spain Site recruitment: Not reported
Investigational Site Number 7240003 Quart de Poblet, Spain Site recruitment: Not reported
Investigational Site Number 7240006 Sabadell, Spain Site recruitment: Not reported
Investigational Site Number 7240007 Seville, Spain Site recruitment: Not reported
Investigational Site Number 7240009 Seville, Spain Site recruitment: Not reported
Investigational Site Number 7240004 Seville, Spain Site recruitment: Not reported
